C4 Therapeutics Inc. (CCCC)
3.93
0.19 (5.08%)
At close: Jan 15, 2025, 10:01 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 20.76M | 31.10M | 45.78M | 33.20M | 21.38M | 19.36M |
| Cost of Revenue | 117.71M | 7.57M | 2.91M | 77.47M | 47.66M | 28.59M |
| Gross Profit | -96.95M | 23.52M | 42.88M | -44.27M | -26.28M | -9.23M |
| Operating Income | -139.03M | -129.53M | -82.13M | -60.45M | -35.45M | -16.39M |
| Interest Income | 9.81M | 3.58M | 387.00K | 393.00K | 1.83M | 685.00K |
| Pretax Income | -131.21M | -128.18M | -83.89M | -66.96M | -33.30M | -15.71M |
| Net Income | -132.49M | -126.50M | -86.04M | -66.33M | -34.10M | -15.71M |
| Selling & General & Admin | 42.08M | 42.79M | 33.25M | 15.20M | 8.77M | 7.16M |
| Research & Development | 117.71M | 117.84M | 94.67M | 78.44M | 48.06M | 28.59M |
| Other Expenses | n/a | n/a | n/a | n/a | 325.00K | -7.00K |
| Operating Expenses | 159.79M | 160.63M | 127.92M | 93.64M | 56.83M | 35.75M |
| Interest Expense | 1.37M | 2.22M | 2.15M | 1.23M | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 159.79M | 160.63M | 127.92M | 93.64M | 56.83M | 35.75M |
| Income Tax | 1.28M | -1.68M | 2.15M | -626.00K | 804.00K | 678.00K |
| Shares Outstanding (Basic) | 49.64M | 48.86M | 46.04M | 43.06M | 42.99M | 14.79M |
| Shares Outstanding (Diluted) | 49.64M | 48.86M | 46.04M | 43.06M | 42.99M | 42.09M |
| EPS (Basic) | -2.67 | -2.59 | -1.87 | -1.54 | -0.79 | -1.06 |
| EPS (Diluted) | -2.67 | -2.59 | -1.87 | -1.54 | -0.79 | -1.06 |
| EBITDA | -122.10M | -124.28M | -78.84M | -62.89M | -30.56M | -15.12M |
| Depreciation & Amortization | 7.74M | 7.57M | 2.91M | 2.84M | 2.74M | 3.57M |